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http://dx.doi.org/10.1016/j.kjms.201Abstract Malignant fibrous histiocytoma is a soft tissue sarcoma that most commonly occurs
in the extremities and rarely metastasizes cutaneously. A 79-year-old male patient consulted
a dermatologist 11 months after recognizing an intractable ulcer on the right mandible. Punch
biopsy revealed eosinophilic tumor cells in the dermal area and proliferation of rich spindle
cells. Malignant fibrous histiocytoma or atypical fibroxanthoma was suspected and he was
referred to our hospital. Red plaque tumors on the right mandible and right temple were
30 mm and 15 mm in size, respectively. The right mandible lesion was ulcerated. Immunohis-
tochemically, the lesions were positive for CD10, CD74 and alpha-smooth muscle actin. Radio-
logical analysis revealed multiple organ metastases, including bone, liver, lung and skin on the
right temple. The patient was diagnosed with malignant fibrous histiocytoma, stage IV and died
8 weeks after the first visit due to respiratory failure. Cutaneous malignant fibrous histiocyto-
ma has a poor prognosis resulting in death.
Copyright ª 2012, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Malignant fibrous histiocytoma (MFH) rarely occurs as
a primary cutaneous tumor [1]. Only a few cases oft of Geriatric and Environ-
ol of Medical, Nagoya City
jp (S. Suzuki).
hsiung Medical University. Publish
2.08.019cutaneous presentation as a metastatic tumor have been
reported [2,3]. Presentation as a cutaneous MFH is impor-
tant for two reasons:
C It may be a primary tumor and thus curable if treated
appropriately [2].
C If the cutaneous tumor is a metastatic tumor from
another site, the prognosis could be very poor [3].ed by Elsevier Taiwan LLC. All rights reserved.
112 S. Suzuki et al.We report a case of cutaneous MFH on the right mandible
with multiple metastases to the skin on the right temple
and other organs.Case report
A 79-year-old male patient with a history of schizophrenia
and Parkinson’s disease presenting with tumors on his
right mandible and right temple was referred to our
hospital (Fig. 1A). The patient had recognized an intrac-
table ulcer on the right mandible 12 months before
consulting us. He consulted an orthopedic surgeon for his
lumbago 5 months prior to consulting us. Magnetic reso-
nance and bone scintigraphy showed space-occupying
lesions on the third and fourth vertebrae and on the left
humerus (Fig. 2A and B). Computed tomography-guided
aspiration cytodiagnosis was conducted, but the spec-
imen comprised a hematoma and no atypical cells were
found. The patient refused another cytodiagnosis. He had
noticed a tumor on the right temple 3 months before
consulting us and had visited a local dermatologist. A skin
biopsy of the intractable ulcer on the right mandible was
performed and histology revealed that the tumor was
either an MFH or an atypical fibroxanthoma (AFX). The
patient was then referred to us.
At the first visit, the tumor on the right temple
appeared as red nodule that was 15 mm at its largest
diameter (Fig. 1B). The tumor on the right mandible was
30 mm across at its largest point, and comprisedFigure 1. The tumors on the right mandible and right temple on
tumors was 30 mm on the right mandible and 15 mm on the right te
The tumor on the right mandible consisted of a nodule on the oute
right temple showed no specific feature other than a brown pigm
telangiectasia.a nodule on the outer edge and an ulcer in the middle
(Fig. 1C). Dermoscopy showed no specific features
(Fig. 1DeE).
Laboratory testing showed normocytic anemia with
a hemoglobin level of 8.4 g/dl and hematocrit of 26.7%.
Blood chemistry revealed hypoproteinemia (5.9 g/dl),
hypoalbuminemia (2.6 g/dl), high blood urea nitrogen
(23.0 mg/dl), elevated lactate dehydrogenase level (459
U/l), and elevated alkaline phosphatase level (801 U/l).
The computed tomography image of the head showed that
the tumor on the right mandible was 27  26  25 mm3 in
size and the boundary against the right geniohyoid muscle
was partially irregular. In the fluorodeoxyglucose positron
emission tomography images, abnormal accumulations
were seen in the right mandible, the vertebrae, costae,
and other bones of the extremities. Multiple accumula-
tions in the liver and both sides of the lungs were also
observed (Fig. 2CeE).
Histopathological examination showed ill-defined
cellular proliferation of spindle cells with enlarged, pleo-
morphic nuclei, showing a storiform pattern (Fig. 3A). The
mitotic count was high, with each high-power field con-
taining 1e4 mitotic cells and bizarre cells (Fig. 3B). The
material was taken as a trephine biopsy specimen and the
tumor had invaded the subcutaneous fat (Fig. 3C). Immu-
nohistochemically, tumor cells were positive with CD10,
alpha-smooth muscle actin, and CD74 (Fig. 3DeF); it was
negative with CD34, CD68, S100, cytokeratins (AE1/AE3),
leukocyte common antigen, desmin, caldesmon, and
calponin.the first day of consultation. (A) The largest diameter of the
mple. (B) The tumor on the right temple was a red nodule. (C)
r edge and an ulcer in the middle. (D) The dermoscopy of the
entation. (E) The dermoscopy of the right mandible showed
Figure 2. Magnetic resonance imaging (MRI) and bone scintigraphy conducted by the orthopedist 5 months prior to consulting us
(A, B) and fluorodeoxyglucose-positron emission tomography images after consulting us (CeE). (A) T1-weighted MRI revealed low
signal areas indicating space-occupying lesions on the third and fourth vertebrae (arrows). (B) Bone scintigraphy showed focal
accumulation on the left humerus (arrow) as well as the third and fourth vertebrae. (C) Abnormal accumulations were seen in the
vertebrae, costae, and other bones of the extremities. (D) Multiple accumulations were observed in the liver. (E) There were
abnormal accumulations in both lungs.
Cutaneous malignant fibrous histiocytoma 113We diagnosed the tumor as MFH of the right mandible
with multiple organ metastases to lung, liver, bone, and the
skin on the right temple. Among the histological subtypes of
MFH, the present case was subclassifed as pleomorphic
type because the tumor contained no conspicuous giant
cells, no myxoid stroma, and no significant inflammatory
infiltrate. We explained to the patient that his illness was
serious and there was no treatment to improve the prog-
nosis and the patient stated that he did not desire further
treatment. He died 8 weeks after the first visit due to
respiratory failure while in a nursing home.
Discussion
MFH is a common soft tissue sarcoma that occurs most
frequently in the extremities, with most cases occurring in
people between 50 and 70 years of age [1]. Histologically,
MFH is characterized by spindle-shaped or round cells with
multinucleation, pleomorphism, and numerous mitoses,
and shows a storiform pattern. MFH is indistinguishable
from that of AFX, which rarely metastasizes to other
organs. If a tumor is larger than 2 cm, extensively involves
the subcutis, penetrates the fascia and muscle, or displays
necrosis or vascular invasion, it should be diagnosed as MFH
[4]. The patient in the present case had a tumor that was
3 cm in size, which had proliferated into the dermis and
subcutaneous fat layers, and had an ulcerated surface.
Radiological study revealed suspected multiple metastasesof the tumor to bone, lung, and liver. We concluded all
these lesions had metastasized from the same tumor for the
following reasons.
C Since all these facts occurred within 1 year, it is more
natural to consider that all the lesions originated from
the same tumor, rather than that more than two
different tumors appeared at the same time.
C Multiple lesions detected by an orthopedic surgeon 5
months earlier with magnetic resonance imaging had
increased by the time the patient came to us. We
believe that the metastases from the same origin
would have spread.These clinical findings strongly supported the diagnosis
of MFH over AFX.
Immunohistochemistry showed that the present case
was positive for CD74. Lazova et al. [5] retrospectively
examined 20 MFH cases and 20 AFX cases and reported that
90% of the MFH cases were positive for CD74, whereas 90%
of the AFX cases were negative for CD74. It is noteworthy
that CD74-positive AFX tends to have a more aggressive
behavior [6]. Positivity of CD74 in our case supports the
diagnosis of MFH.
Among other differential diagnoses of spindle cell
sarcomas, dermatofibrosarcoma protuberans is charac-
teristically CD34 positive, but our case was negative for
CD34. Fibrosarcoma is generally less pleomorphic, and
Figure 3. Histopathological examination of the tumor of the right mandible. (A) Proliferation of atypical tumor cells in the dermis.
(B) Mitotic count (in the red circle) is high, each high-power filed containing 1e4 mitotic cells and bizarre cells (in the yellow circle).
(C) The tumor cells were pleomorphic spindle cells partially arranged in a storiform pattern. (DeF) The tumor cells were positively
stained with CD10 (D), alpha-smooth muscle actin (E), and CD74 (F). Hematoxylin and eosin staining; original magnifications20 (A),
400 (B) and 200 (C); CD10, alpha-SMA, and CD74 immunocytochemistry, original magnification 400 (DeF)].
114 S. Suzuki et al.sometimes shows a herringbone pattern. Malignant
peripheral nerve sheath tumor is often associated with
nerves and may show S-100 protein positivity. Leiomyo-
sarcoma is defined as a sarcoma showing more than two of
four known markers of smooth muscle differentiation
[7,8]. Our present case only shows positivity on smooth
muscle actin, and thus does not satisfy the immunohisto-
chemical criteria for leiomyosarcoma.
The rate of local recurrence for MFH ranges between 19%
and 31% and metastasis occurs in 31e35% of patients after
the tumor resection. The 5-year survival rate ranges from
65 to 70%. The common sites of metastasis are lung (90%),
bone (8%), and liver (1%) [4]. In the present case, we esti-
mated that the primary site was the right mandible, with
metastases to the skin of the right temple as well as to the
lung, bone and liver. Among the eight reported cases of
cutaneous metastases of MFH, only two cases reported
duration of survival; one case survived for 2 years and one
survived for 10 weeks [3].
For the treatment of cutaneous MFH, it is essential
to perform a wide excision of the tumor as early aspossible [2]. Adjuvant radiotherapy may be effective in
some cases, but the efficacy of chemotherapy remains
questionable [1,9,10]. For cases with cutaneous metas-
tases, the effect of these treatments is unclear due to the
limited number of reported cases [3]. It is important to note
that cutaneous MFH with metastases may result in abrupt
death of the patient.References
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